Cargando…
Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report
Follicular dendritic cell sarcoma (FDCS) is an uncommon low-grade malignant sarcoma. For localized FDCS, surgery is the most commonly recommended therapy option. However, there is no standard treatment protocol for metastatic FDCS. Here, we present a 68-year-old female with primary spleen FDCS who h...
Autores principales: | Li, Jielang, Ren, Min, Bi, Feng, Chen, Ye, Li, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485249/ https://www.ncbi.nlm.nih.gov/pubmed/37691960 http://dx.doi.org/10.3389/fimmu.2023.1228653 |
Ejemplares similares
-
Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review
por: Lei, Yanna, et al.
Publicado: (2021) -
PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas
por: Tian, Zhichao, et al.
Publicado: (2022) -
Mediastinal Follicular Dendritic Cell Sarcoma With Underlying Sjogren’s Syndrome
por: Phrathep, Davong D, et al.
Publicado: (2023) -
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
por: Zhang, Xuanye, et al.
Publicado: (2022) -
Follicular dendritic cell sarcoma treated with a variety of chemotherapy
por: Sasaki, Masaoki, et al.
Publicado: (2016)